Your browser doesn't support javascript.
loading
Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis.
Stillger, Maren Nicole; Chen, Chia-Yi; Lai, Zon Weng; Li, Mujia; Schäfer, Agnes; Pagenstecher, Axel; Nimsky, Christopher; Bartsch, Jörg Walter; Schilling, Oliver.
Afiliação
  • Stillger MN; Institute for Surgical Pathology, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Chen CY; Faculty of Biology, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Lai ZW; Institute for Surgical Pathology, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Li M; Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, USA.
  • Schäfer A; Institute for Surgical Pathology, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Pagenstecher A; Department of Pharmaceutical Biology and Biotechnology, Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.
  • Nimsky C; Department of Neurosurgery, Philipps-University Marburg, Marburg, Germany.
  • Bartsch JW; Institute of Neuropathology, Philipps-University, Marburg, Germany.
  • Schilling O; Center for Mind, Brain and Behavior, CMBB, Marburg University, Hans-Meerwein-Strasse 6, 35032, Marburg, Germany.
Cancer Cell Int ; 23(1): 49, 2023 Mar 17.
Article em En | MEDLINE | ID: mdl-36932402

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article